Rydzewski Bartosz, Dehdashti Farrokh, Gordon Brigid A, Teefey Sharlene A, Strasberg Steven M, Siegel Barry A
Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd., St. Louis, MO 63110, USA.
AJR Am J Roentgenol. 2002 Feb;178(2):353-8. doi: 10.2214/ajr.178.2.1780353.
The purpose of this study was to compare the diagnostic performance of preoperative positron emission tomography (PET) with FDG and intraoperative sonography with the standard of histologic examination of resected liver specimens in evaluating patients for curative resection of liver metastases from colorectal cancer.
We retrospectively identified 47 patients with recurrent colorectal cancer who underwent surgical exploration for possible curative resection of hepatic metastases. All patients underwent CT or MR imaging and FDG PET preoperatively and intraoperative sonography. The performance of the imaging techniques was evaluated through review of the radiologic reports and correlation with surgical and histopathologic findings.
Eighty-seven malignant hepatic lesions were identified by histopathologic analysis of liver specimens, and 23 benign hepatic abnormalities were documented histopathologically or by uroradiologic imaging. For hepatic sections characterized as containing metastases by radiologic imaging, the positive predictive value for FDG PET was 93% (54/58); for intraoperative sonography, 87% (52/60); and for conventional imaging, 83% (43/52). For individual lesions characterized as probably malignant, the positive predictive value for FDG PET was 93% (62/68); for intraoperative sonography, 89% (63/71); and for conventional imaging, 78% (46/59). The findings at intraoperative sonography led to a change in the clinical treatment of only one patient (2%).
The results indicate that FDG PET effectively screens potential candidates for curative liver resection. Although intraoperative sonography helps to determine the anatomic location of metastases thus facilitating surgical resection, its adjunctive use in patients screened preoperatively by FDG PET has limited impact on treatment selection.
本研究旨在比较术前正电子发射断层扫描(PET)联合氟代脱氧葡萄糖(FDG)与术中超声检查,与切除的肝标本组织学检查标准相比,在评估结直肠癌肝转移患者是否适合进行根治性切除方面的诊断性能。
我们回顾性纳入了47例复发性结直肠癌患者,这些患者接受了手术探查,以评估是否有可能对肝转移灶进行根治性切除。所有患者术前均接受了CT或MR成像、FDG PET检查以及术中超声检查。通过回顾放射学报告并与手术及组织病理学结果进行对比,对这些成像技术的性能进行了评估。
通过肝标本的组织病理学分析确定了87个恶性肝病灶,并且通过组织病理学或泌尿放射学成像记录了23个良性肝异常。对于经放射学成像判定为含有转移灶的肝切片,FDG PET的阳性预测值为93%(54/58);术中超声检查为87%(52/60);传统成像为83%(43/52)。对于判定为可能为恶性的单个病灶,FDG PET的阳性预测值为93%(62/68);术中超声检查为89%(63/71);传统成像为78%(46/59)。术中超声检查的结果仅导致1例患者(2%)的临床治疗方案发生改变。
结果表明,FDG PET能有效筛选出适合进行根治性肝切除的潜在患者。虽然术中超声检查有助于确定转移灶的解剖位置,从而便于手术切除,但在术前经FDG PET筛选的患者中辅助使用术中超声检查对治疗选择的影响有限。